Ayvakit
Term · Oncology and biomedicine · MLC-T-ONC-000875
A drug used to treat adults with advanced systemic mastocytosis or certain types of gastrointestinal stromal tumors. It is also being studied in the treatment of other types of cancer. Ayvakit blocks certain proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called avapritinib.
| Identifier | MLC-T-ONC-000875 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | avapritinib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000875",
"term": "Ayvakit",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with advanced systemic mastocytosis or certain types of gastrointestinal stromal tumors. It is also being studied in the treatment of other types of cancer. Ayvakit blocks certain proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called avapritinib.",
"synonyms": [
"avapritinib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ayvakit/"
}
Record 3,207 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.